Chemical and genetic control of IFNγ-induced MHCII expression

Area of Science:

• Immunology
• Molecular Biology
• Epigenetics

Background:

• Interferon-γ (IFNγ) induces MHC class II (MHCII) expression, crucial for CD4+ T cell activation, anti-tumour immunity, and graft-versus-host disease.
• MHCII upregulation by IFNγ is cell-type specific and regulated by epigenetic factors and signaling pathways.

Purpose of the Study:

• Identify novel genetic and chemical factors controlling IFNγ-mediated MHCII expression.
• Elucidate the link between oxidative stress, epigenetic modifications, and MHCII regulation.

Main Methods:

• Investigated the impact of genetic factors (Keap1, p62/SQSTM1, Cullin-3, BPTF) on IFNγ-induced MHCII expression.
• Assessed the effects of arsenite (oxidative stressor) and dimethyl fumarate (antioxidant) on MHCII expression.
• Examined the role of HDAC1/2 inhibition in reversing arsenite-induced effects.

Main Results:

• Loss of Keap1, p62/SQSTM1, Cullin-3, or BPTF impairs IFNγ-mediated MHCII upregulation.
• Arsenite exposure mimics this impairment, an effect reversible by HDAC1/2 inhibition.
• Dimethyl fumarate interferes with IFNγ response by altering MHCII transcriptional control.

Conclusions:

• Novel pathways involving oxidative stress, epigenetic regulators (HDAC1/2), and specific genes control IFNγ-induced MHCII expression.
• Findings provide a molecular basis for understanding MHCII-associated diseases and suggest potential therapeutic targets.